Bullous pemphigoid possibly triggered and exacerbated by ophthalmic preparations.
D
D
Spivak
E
E
Orion
S
S
Brenner
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D002040:Levobunolol / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009061:Mouth Mucosa; D009883:Ophthalmic Solutions; D010391:Pemphigoid, Bullous / Q000139:chemically induced* / Q000175:diagnosis; D013449:Sulfonamides / Q000009:adverse effects*; D013876:Thiophenes / Q000009:adverse effects*; D013999:Timolol / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D009883:Ophthalmic Solutions; D013449:Sulfonamides; D013876:Thiophenes; D013999:Timolol; C062765:dorzolamide; D002040:Levobunolol